Nov 202617–20
International Celiac Disease Symposium (ICDS 2026)
Date: November 17–20, 2026 · Location: Melbourne, Australia
Interlude Biopharma will be featured in the digital conference program for ICDS 2026, an international gathering of researchers, clinicians, and industry leaders focused on advancing celiac disease research, diagnosis, and treatment.
Interlude is advancing larazotide acetate, an investigational, first-in-class oral tight junction regulator designed to protect the intestinal barrier against gluten-induced injury in people with celiac disease, as an adjunct to the gluten-free diet.
Learn more about ICDS 2026